CN103239705A - 一种鳄鱼胶原蛋白抗菌肽的组合物及其制备方法 - Google Patents
一种鳄鱼胶原蛋白抗菌肽的组合物及其制备方法 Download PDFInfo
- Publication number
- CN103239705A CN103239705A CN2013101751126A CN201310175112A CN103239705A CN 103239705 A CN103239705 A CN 103239705A CN 2013101751126 A CN2013101751126 A CN 2013101751126A CN 201310175112 A CN201310175112 A CN 201310175112A CN 103239705 A CN103239705 A CN 103239705A
- Authority
- CN
- China
- Prior art keywords
- antibacterial peptide
- collagen protein
- crocodile
- preparation
- enzymolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 title claims abstract description 55
- 241000270722 Crocodylidae Species 0.000 title claims abstract description 54
- 102000008186 Collagen Human genes 0.000 title claims abstract description 51
- 108010035532 Collagen Proteins 0.000 title claims abstract description 51
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229920001436 collagen Polymers 0.000 title abstract description 7
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 23
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 claims abstract description 21
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 19
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 238000005303 weighing Methods 0.000 claims abstract description 4
- 239000004365 Protease Substances 0.000 claims description 42
- 102000004190 Enzymes Human genes 0.000 claims description 36
- 108090000790 Enzymes Proteins 0.000 claims description 36
- 210000000988 bone and bone Anatomy 0.000 claims description 36
- 229940088598 enzyme Drugs 0.000 claims description 36
- 108091005804 Peptidases Proteins 0.000 claims description 34
- 235000019419 proteases Nutrition 0.000 claims description 33
- 241001465754 Metazoa Species 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 102000057297 Pepsin A Human genes 0.000 claims description 11
- 108090000284 Pepsin A Proteins 0.000 claims description 11
- 229940111202 pepsin Drugs 0.000 claims description 11
- 108090000145 Bacillolysin Proteins 0.000 claims description 10
- 108091005658 Basic proteases Proteins 0.000 claims description 10
- 102000035092 Neutral proteases Human genes 0.000 claims description 10
- 108091005507 Neutral proteases Proteins 0.000 claims description 10
- 108090000526 Papain Proteins 0.000 claims description 9
- 235000019834 papain Nutrition 0.000 claims description 9
- 229940055729 papain Drugs 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000005345 coagulation Methods 0.000 claims description 3
- 230000015271 coagulation Effects 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 230000009849 deactivation Effects 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- 235000014593 oils and fats Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 claims description 2
- 101710176384 Peptide 1 Proteins 0.000 claims description 2
- 235000019628 coolness Nutrition 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 206010003246 arthritis Diseases 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 229920002774 Maltodextrin Polymers 0.000 abstract 2
- 239000005913 Maltodextrin Substances 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 2
- 230000001070 adhesive effect Effects 0.000 abstract 2
- 239000010419 fine particle Substances 0.000 abstract 2
- 229940035034 maltodextrin Drugs 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 description 33
- 230000007062 hydrolysis Effects 0.000 description 24
- 238000006460 hydrolysis reaction Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 11
- 238000007792 addition Methods 0.000 description 11
- 230000003385 bacteriostatic effect Effects 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 210000001188 articular cartilage Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 230000001408 fungistatic effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 208000012659 Joint disease Diseases 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- -1 N-acetylamino galactosamine Chemical compound 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000001258 synovial membrane Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- KVYRCBOUKXJXDK-UHFFFAOYSA-N 3,4-dimethylphenazine-1,2-diamine hydrochloride Chemical compound Cl.C1=CC=CC2=NC3=C(C)C(C)=C(N)C(N)=C3N=C21 KVYRCBOUKXJXDK-UHFFFAOYSA-N 0.000 description 1
- 229910000851 Alloy steel Inorganic materials 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000369611 Cymbacephalus beauforti Species 0.000 description 1
- 241000086550 Dinosauria Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710180319 Protease 1 Proteins 0.000 description 1
- 101710180316 Protease 2 Proteins 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 1
- 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
- LDKDGDIWEUUXSH-UHFFFAOYSA-N Thymophthalein Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C LDKDGDIWEUUXSH-UHFFFAOYSA-N 0.000 description 1
- 101710119642 Trypsin-3 Proteins 0.000 description 1
- 102100034396 Trypsin-3 Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000001510 arthropathic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
酶种类 | pH | 温度/℃ |
动物复合蛋白酶 | 7.0 | 55 |
风味蛋白酶 | 7.4 | 50 |
碱性蛋白酶 | 8.5 | 60 |
中性蛋白酶 | 7.0 | 50 |
胃蛋白酶 | 3.0 | 37 |
木瓜蛋白酶 | 7.0 | 50 |
胰蛋白酶 | 8.0 | 37 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310175112.6A CN103239705B (zh) | 2013-05-10 | 2013-05-10 | 一种鳄鱼胶原蛋白抗菌肽的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310175112.6A CN103239705B (zh) | 2013-05-10 | 2013-05-10 | 一种鳄鱼胶原蛋白抗菌肽的组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103239705A true CN103239705A (zh) | 2013-08-14 |
CN103239705B CN103239705B (zh) | 2015-07-15 |
Family
ID=48919808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310175112.6A Active CN103239705B (zh) | 2013-05-10 | 2013-05-10 | 一种鳄鱼胶原蛋白抗菌肽的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103239705B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665137A (zh) * | 2013-11-08 | 2014-03-26 | 广州和仕康生物技术有限公司 | 美洲短吻鳄Cathelicidin-AM抗菌肽及其编码序列和用途 |
CN104372056A (zh) * | 2014-11-13 | 2015-02-25 | 华侨大学 | 一种利用章鱼下脚料获得抗氧化活性物质和复合氨基酸的方法 |
CN105367648A (zh) * | 2015-11-10 | 2016-03-02 | 莫骏荣 | 一种用鳄鱼尾胶提取胶原蛋白方法 |
CN105463046A (zh) * | 2016-01-18 | 2016-04-06 | 广州市鼍龙生物技术开发有限公司 | 一种鳄鱼骨胶原蛋白肽粉的制备方法及其用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101648008A (zh) * | 2009-09-04 | 2010-02-17 | 江苏江山制药有限公司 | 用于关节保健的复合制剂及其制备方法 |
CN101829125A (zh) * | 2010-05-27 | 2010-09-15 | 江苏江山制药有限公司 | 用于防治骨关节痛的复方组合制剂及其制备方法 |
CN101961110A (zh) * | 2010-10-14 | 2011-02-02 | 马宏达 | 营养软骨抗关节炎症的功能食品制备方法 |
CN102342404A (zh) * | 2011-09-23 | 2012-02-08 | 北京东方红航天生物技术股份有限公司 | 一种复合钙制剂 |
CN102600458A (zh) * | 2011-11-01 | 2012-07-25 | 江苏江山制药有限公司 | 一种氨糖软骨素的复方制剂及其制作方法 |
-
2013
- 2013-05-10 CN CN201310175112.6A patent/CN103239705B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101648008A (zh) * | 2009-09-04 | 2010-02-17 | 江苏江山制药有限公司 | 用于关节保健的复合制剂及其制备方法 |
CN101829125A (zh) * | 2010-05-27 | 2010-09-15 | 江苏江山制药有限公司 | 用于防治骨关节痛的复方组合制剂及其制备方法 |
CN101961110A (zh) * | 2010-10-14 | 2011-02-02 | 马宏达 | 营养软骨抗关节炎症的功能食品制备方法 |
CN102342404A (zh) * | 2011-09-23 | 2012-02-08 | 北京东方红航天生物技术股份有限公司 | 一种复合钙制剂 |
CN102600458A (zh) * | 2011-11-01 | 2012-07-25 | 江苏江山制药有限公司 | 一种氨糖软骨素的复方制剂及其制作方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665137A (zh) * | 2013-11-08 | 2014-03-26 | 广州和仕康生物技术有限公司 | 美洲短吻鳄Cathelicidin-AM抗菌肽及其编码序列和用途 |
CN103665137B (zh) * | 2013-11-08 | 2015-07-01 | 广州和仕康生物技术有限公司 | 美洲短吻鳄Cathelicidin-AM抗菌肽及其编码序列和用途 |
CN104372056A (zh) * | 2014-11-13 | 2015-02-25 | 华侨大学 | 一种利用章鱼下脚料获得抗氧化活性物质和复合氨基酸的方法 |
CN105367648A (zh) * | 2015-11-10 | 2016-03-02 | 莫骏荣 | 一种用鳄鱼尾胶提取胶原蛋白方法 |
CN105463046A (zh) * | 2016-01-18 | 2016-04-06 | 广州市鼍龙生物技术开发有限公司 | 一种鳄鱼骨胶原蛋白肽粉的制备方法及其用途 |
CN105463046B (zh) * | 2016-01-18 | 2020-03-17 | 广州市鼍龙生物技术开发有限公司 | 一种鳄鱼骨胶原蛋白肽粉的制备方法及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN103239705B (zh) | 2015-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105132318B (zh) | 植物乳杆菌Grx16及其应用 | |
CN109349419B (zh) | 一种修复人体细胞的复合牦牛骨胶原蛋白肽粉 | |
CN102251006B (zh) | 一种东海乌参胶原蛋白的制造方法 | |
Zeng et al. | Structure and immunomodulatory activity of polysaccharides from Fusarium solani DO7 by solid-state fermentation | |
CN101423854A (zh) | 一种用褐藻胶裂解酶制备褐藻胶寡糖的方法 | |
CN103239705B (zh) | 一种鳄鱼胶原蛋白抗菌肽的组合物及其制备方法 | |
CN105255974A (zh) | 一种利用枯草芽孢杆菌发酵罗非鱼鱼皮制备抗氧化活性肽的方法 | |
CN105002249B (zh) | 一种红曲霉液态发酵制备ace抑制肽的方法 | |
US20240262888A1 (en) | Method for preparing non-denatured type ii collagen | |
CN109207544A (zh) | 一种小球藻抗氧化多肽的制备方法 | |
CN102718832A (zh) | 海洋生物胶原多肽 | |
CN105255972A (zh) | 一种利用米曲霉发酵罗非鱼鱼皮制备抗氧化活性肽的方法 | |
CN104095183B (zh) | 一种海藻多糖的应用 | |
CN104311645B (zh) | 具有抑菌活性的螺旋藻多肽p1及其应用 | |
CN101050467B (zh) | 一种高活性鸡溶菌酶的基因克隆、表达与应用 | |
KR100710275B1 (ko) | 바실러스속 미생물을 이용한 대두피 또는 흑두피 발효방법,그리고 및 대두피 또는 흑두피 발효물을 함유하는 조성물 | |
CN102533916A (zh) | 一种珠蚌抗氧化肽的生产方法 | |
CN103088095A (zh) | 一种羊角蛋白肽的制备方法 | |
CN102978187B (zh) | 一种pH 2.5~6.5范围内有高活性的β-甘露聚糖酶MAN5A及其基因和应用 | |
CN105255982A (zh) | 一种利用米曲霉发酵罗非鱼鱼皮制备抗氧化活性肽的方法 | |
CN107913397B (zh) | 一种微生态妇科洗液及其制备方法 | |
CN1951402A (zh) | 一种海参活性多肽钙、锌蛋白的生产方法 | |
CN111165750A (zh) | 一种利用发酵技术制备海参花粉剂的方法 | |
CN105200107B (zh) | 瘤背石磺肌肉粗蛋白的提取方法 | |
CN115212154A (zh) | 一种藤茶发酵滤液的制备方法及其在化妆品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU SHANKANG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG HUADONG Effective date: 20150908 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150908 Address after: Guangzhou Yuexiu District City, Guangdong province 510000 Dongfeng Road No. 515, room 2306 - 2305 Patentee after: Shan Kang bio tech ltd, Guangzhou Address before: 510000, Guangzhou, Guangdong province Yuexiu District Temple right 18 road, Tai Heng building, 2209 Patentee before: Wang Huadong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200401 Address after: 526200 Guangdong city of Zhaoqing Province Sihui City Du Gang ho Tsai Liuzhou Patentee after: GUANGDONG ZHENSHAN CROCODILE BREEDING Co.,Ltd. Address before: Guangzhou Yuexiu District City, Guangdong province 510000 Dongfeng Road No. 515, room 2306 - 2305 Patentee before: GUANGZHOU SHANKANG BIOTECHNOLOGY Co.,Ltd. |